申请人:Boehringer Ingelheim International GmbH
公开号:EP2471787A1
公开(公告)日:2012-07-04
The present invention encompasses compounds of general formula (1)
wherein
R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.
本发明包括通式(1)的化合物
其中
R1 至 R4 的定义如权利要求 1 所述,它们适用于治疗以细胞过度增殖或异常增殖为特征的疾病,并可用于制备具有上述性质的药物。